The American Journal of Medicine
Volume 122, Issue 4 , Pages 356-365, April 2009

Long-Acting Calcium Antagonists in Patients with Coronary Artery Disease: A Meta-Analysis

This work was presented in part at the Annual Scientific Session of the American College of Cardiology, New Orleans, Louisiana, 2007.

  • Sripal Bangalore, MD, MHA
  • ,
  • Sanobar Parkar, MD, MPH
  • ,
  • Franz H. Messerli, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Franz H. Messerli, MD, Director, Hypertension Program, Division of Cardiology, St. Luke's-Roosevelt Hospital, 1000 10th Avenue, Suite 3B-30, New York, NY 10019

Department of Medicine, Division of Cardiology, St. Luke's Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: None.

 Conflicts of Interest: Sripal Bangalore: no disclosures; Sanobar Parkar: no disclosures; Franz H Messerli: Speakers' Bureau—Abbott, GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Forest, Sankyo, Sanofi. Research/Grants—GlaxoSmithKline, Pfizer, Novartis, CardioVascular Therapeutics.

 Authorship: All authors had access to the data and had a role in writing the manuscript.

PII: S0002-9343(08)01104-2

doi:10.1016/j.amjmed.2008.09.043

The American Journal of Medicine
Volume 122, Issue 4 , Pages 356-365, April 2009